| +0.27 / +1.14%|
The 6 analysts offering 12-month price forecasts for Durata Therapeutics Inc have a median target of 23.00, with a high estimate of 25.00 and a low estimate of 22.00. The median estimate represents a -3.97% decrease from the last price of 23.95.
The current consensus among 8 polled investment analysts is to Hold stock in Durata Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.